A detailed history of Rise Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Rise Advisors, LLC holds 224 shares of INCY stock, worth $23,329. This represents 0.01% of its overall portfolio holdings.

Number of Shares
224
Previous 211 6.16%
Holding current value
$23,329
Previous $14,000 28.57%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

BUY
$67.27 - $86.96 $874 - $1,130
13 Added 6.16%
224 $18,000
Q2 2025

Jul 08, 2025

BUY
$55.17 - $71.22 $1,820 - $2,350
33 Added 18.54%
211 $14,000
Q1 2025

May 15, 2025

SELL
$60.0 - $75.26 $7,920 - $9,934
-132 Reduced 42.58%
178 $10,000
Q1 2024

Apr 09, 2024

BUY
$56.55 - $66.59 $17,530 - $20,642
310 New
310 $17,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.